<DOC>
	<DOCNO>NCT02905305</DOCNO>
	<brief_summary>In effort preserve residual acoustic hearing cochlear implantation , may beneficial incorporate anti-inflammatory agent electrode array passive elution time course implantation . This study aim assess ease effectiveness electrode design , assess preliminary safety use device post-operative period . This study first-time-in-human study investigational device . In first instance , aim current investigation obtain first experience use Combined Device adult clinical population , assess tool technique may consider future clinical study similar device .</brief_summary>
	<brief_title>Cochlear Implant With Anti-Inflammatory Agent</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Duration severe profound hearing impairment implant ear less equal 30 year 2 . Postlingual hearing impairment define onset hearing loss great two year age 3 . Evidence Pneumovax vaccination within three year implantation date ( subject implant investigational device ) 1 . Ossification cochlear anomaly might prevent complete insertion electrode array increase risk infection ( i.e . dysplastic cochlea ) , confirm medical examination image include MRI 2 . Current use grommet evidence tympanic membrane perforation 3 . Known allergic reaction dexamethasone similar medicine 4 . Diagnosis Auditory Neuropathy 5 . Active middle ear infection history middle ear infection within past two year 6 . Unrealistic expectation part subject regard possible benefit , risk , limitation inherent surgical procedure use prosthetic device 7 . Unwillingness inability candidate comply investigational requirement 8 . Additional disability would prevent restrict participation audiological medical evaluation require clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>cochlear implant</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>combine device</keyword>
</DOC>